EFSA FEEDAP — niacin (nicotinic acid) — renewal of authorisation
Source: EFSA FEEDAP scientific opinion, EFSA Journal 2023;21(10) (DOI 10.2903/j.efsa.2023.8359), retrieved 2026-08-06 via Europe PMC OA full-text XML. Paraphrase of an EFSA opinion that the source XML tags CC-BY-ND; per project COPYRIGHT_POLICY only facts/numbers/proper-nouns are quoted verbatim, sentences rewritten.
Editorial context (read this before using the data point)
This is the EFSA FEEDAP jurisdiction on the nutrient/additive niacin (nicotinic acid, vitamin B3) — one of five nutrient-safety opinions in this final batch (Task L). Read with the efsa nutrient endpoints and AAFCO/FEDIAF provisions for the same nutrient.
Key findings (paraphrase; numbers and proper nouns verbatim from source)
- This is a renewal-of-authorisation assessment of niacin (nicotinic acid, vitamin B3).
- No new evidence reverses prior conclusions — it remains safe for all animal species, consumers and the environment under authorised conditions.
- User safety: not irritant to skin but irritant to eyes; not a dermal sensitiser; inhalation exposure is likely.
Pet-food relevance
Niacin (vitamin B3) is essential for cats and dogs (energy metabolism, skin). The confirmed 'remains safe' conclusion is the usable takeaway; the eye-irritant (but not skin-sensitiser) profile is the handling note.
Scope note / honest gap
Paraphrase of an EFSA opinion; source XML licence tag was CC-BY-ND, so this topic quotes only data points verbatim and rewrites prose. Renewal opinion (efficacy not re-assessed); full statistics are not reproduced.